Uppsala Monitoring Centre

13/09/2026

Since 2016, we've teamed up with pharmacovigilance and patient safety stakeholders worldwide for – a campaign to raise awareness and encourage reporting of suspected side effects.

In the lead-up to this year's event, we wanted to know: 𝙬𝙝𝙖𝙩 𝙙𝙤𝙚𝙨 #𝙈𝙚𝙙𝙎𝙖𝙛𝙚𝙩𝙮𝙒𝙚𝙚𝙠 𝙢𝙚𝙖𝙣 𝙩𝙤 𝙩𝙝𝙚𝙢?

Our colleagues at the National Pharmaceutical Regulatory Agency in Malaysia🇲🇾 share their Med Safety Story in the film below👇

📆 Join us from 2 to 8 November 2026 as we explore why we should report and not ignore side effects. Learn more 👉 http://ow.ly/XEoc50LlhaJ

Program Perkhidmatan Farmasi KKM Kenali Ubat Anda KKM

11/09/2026

Looking to develop your film skills?

Join UMC's Matthew Barwick at the SCI-COM-E meeting to learn more about visual storytelling, cross-cultural communication, and behaviour change in :

📆 Thursday, 24 September 2026
🕚 11:00 – 12:30
📍Frankfurt Institute for Advanced Studies, Frankfurt 🇩🇪

Learn more and register to attend at this link 👉 https://sci-com.org/conferences/sci-com-e-2026/

10/09/2026

⏳ Last chance to register for a pre-conference course at !

Are you a professional looking to enhance your skills in post-marketing drug safety monitoring? Register to attend this half-day course and dive into global safety surveillance with FDA's and UMC's databases:

📆 Tuesday, 22 September
🕗 08:30 – 12:30 CST

Course objectives:
🔹 Regulatory frameworks and database fundamentals
🔹 Reporting patterns and emerging methods
🔹 Dashboard navigation and data analysis
🔹 Real-world case studies

Register to attend on the conference website 👉 https://www.isop2026costarica.org/

With support from Monica Muñoz (FDA), Leah Herity (FDA), Michele Fusaroli, Niklas Norén, and Levente Pápai (UMC)

09/09/2026

Conventional signal detection methods, such as disproportionality analysis, can generate a considerable review burden for experts.

A new research poster explores how tree-based scan (TBSS) may offer a promising approach. By using the hierarchical structures of and , TBSS can group related adverse events at different levels of aggregation, facilitating signal assessment.

View the poster for more insights 👉 https://ow.ly/YTfK50ZKt2N

Kirthana Nair, Michele Fusaroli, Nhung TH Trinh, Cathrine Axfors, Valentina Giunchi

08/09/2026

webinar: Reciprocal Effects of Drugs & the Microbiome

Research on the microbiome is reshaping our understanding of health, disease, and medicines. Join the second CIOMS webinar to learn more about current evidence, regulatory implications, and priorities for future guidance on drug–microbiome interactions:

📆 Wednesday, 7 October
🕑 14:00 – 15:30 CEST
🖥️ Online

Register 👉 https://ow.ly/Nrba50ZKJNc

07/09/2026

In pharmacovigilance, context is everything. Harmonised methods help countries collaborate, but effective safety monitoring must also reflect local realities, from geographical barriers and limited resources to differing public health priorities.

In the latest episode of , Salvador Alvarado and Matthew Barwick discuss:

🌍 The shared and distinct challenges facing PV professionals worldwide
🤝 How UMC supports the WHO PIDM
🎥️ Practical advice for communicating science on camera

🎧 Listen in today 👉 https://ow.ly/MUQ350ZJhWh

03/09/2026

Could two reports about the same adverse event be better than one?

Analysis of paired reports from the Norwegian🇳🇴 ADR Registry suggests merging consumer and healthcare professional accounts of the same adverse event may improve causality assessment.

Tommy Emil Dzus writes how bringing together these different perspectives may help create more complete individual case safety reports and strengthen activities.

Read for more at the link below👇

Analysis of paired reports from the Norwegian ADR Registry suggests merging consumer and healthcare professional accounts of the same adverse event may improve causality assessment

02/09/2026

The latest research from UMC is on display at 🇮🇹

Our colleagues Michele, Niklas, and Valentina are participating in sessions and sharing research that addresses case identification in , more efficient safety signal triage, and novel approaches to in VigiBase.

If you're in Milan, chat with our colleagues to learn more or access the posters online via the links below👇

🔹 Not All Reports Are Created Equal: Towards a Framework for Case Identification in Pharmacovigilance (B-337)
👉 https://ow.ly/W4B550ZI9aT
🔹 Automated pre-validation can support expert triage of safety signals: Reducing routine screening burden while keeping expert attention where it matters (B-338)
👉 https://ow.ly/SagL50ZI9aV
🔹 Application of Tree-Based Scan Statistics for Hierarchical Signal Detection in VigiBase (B-339)
👉 https://ow.ly/4VUI50ZI9aU

01/09/2026

How can the principles from the CIOMS XIV guidelines on in be applied in practice?

A new publication, featuring contributions from UMC's Niklas Norén, aims to support stakeholders in developing and deploying AI systems in a way that maintains scientific rigour, regulatory compliance, and public trust, while enabling innovation to support the safe use of medicines worldwide.

📖 Read the article at the link below👇

Artificial intelligence (AI) is increasingly being explored to support pharmacovigilance activities including processes involving individual case safety reports. These technologies may improve efficiency and enable new analytical capabilities, but they also raise important questions regarding the re...

30/08/2026

Putting into practice 🌱

Mexico🇲🇽 is implementing new measures to integrate medication and medical device management and related waste streams. Through stricter controls on storage, transport, treatment, destruction, and documentation, the framework aims to reduce contamination of water, soil, and ecosystems while simultaneously limiting opportunities for medicine diversion, misuse, and illegal recycling.

Learn how regulatory action can support both and environmental in at the link below👇

Mexico's new pharmaceutical waste framework puts One Health into practice, from hazardous-waste handling in hospitals to expired pills in the kitchen drawer.